Search images on Google      Product Monograph

Active Ingredients:

• haemagglutinin-strain a (h1n1), 15 MCG/0.5 ML
• haemagglutinin-strain a (h3n2), 15 MCG/0.5 ML
• haemagglutinin-strain b (victoria), 15 MCG/0.5 ML
• haemagglutinin-strain b (yamagata), 15 MCG/0.5 ML

DIN: 02420783

Dosage Form(s): SUSPENSION

Route(s) of Administration: INTRAMUSCULAR

Description: MULTI-DOSE VIAL, WITH PRESERVATIVE

Schedule: Schedule D

Company: ID BIOMEDICAL CORPORATION OF QUEBEC

ATC:

• J07 - VACCINES (ATC, WHO, Wiki)
• J07B - VIRAL VACCINES (ATC, WHO)
• J07BB - Influenza vaccines (ATC, WHO)
• J07BB02 - INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN (WHO)

Reference brand drug:

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 5ML/10X5ML

 

External Links for Flulaval Tetra:

Search on Google

• Flulaval Tetra side effects
• Flulaval Tetra dosage
• haemagglutinin-strain a side effects
• haemagglutinin-strain a dosage
• haemagglutinin-strain a side effects
• haemagglutinin-strain a dosage
• haemagglutinin-strain b side effects
• haemagglutinin-strain b dosage
• haemagglutinin-strain b side effects
• haemagglutinin-strain b dosage